z-logo
Premium
Aloesin up‐regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK‐HEP‐1 cells
Author(s) -
Lee Kwang Youl,
Park Jeong Hill,
Chung Myung Hee,
Park Young In,
Kim Kyu Won,
Lee Young Joo,
Lee Seung Ki
Publication year - 1997
Publication title -
iubmb life
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.132
H-Index - 113
eISSN - 1521-6551
pISSN - 1521-6543
DOI - 10.1080/15216549700201291
Subject(s) - cyclin dependent kinase 2 , cyclin a , cyclin e , cyclin d , microbiology and biotechnology , cycloheximide , cell cycle , cyclin a2 , cyclin dependent kinase complex , biology , cdc25a , intracellular , cyclin dependent kinase , cyclin b , kinase , chemistry , cyclin , biochemistry , protein kinase a , cell cycle checkpoint , cell , protein biosynthesis
Abstract In the present study, we show that aloesin, which is a low molecular weight ingredients present in Aloe vera, stimulates the proliferation of cultured human hepatoma SK‐HEP‐1 cells. The incorporation of [3H] thymidine into DNA in the cell cultures was significantly increased at a dose of 10 μM aloesin. The aloesin‐induced DNA synthesis appears to require newly synthesized proteins because cycloheximide treatment blocked the DNA synthesis evoked by this compound. We then examined whether this compound increases the intracellular levels of cell cycle regulators by immunoblotting. The data showed that aloesin increased the levels of cyclin E, CDK2, and CDC25A in SK‐HEP‐1 cells. In addition, immuno‐complex kinase assays showed that aloesin up‐regulated the enzyme activity of cyclin E/CDK2 kinase in a dose‐dependent manner. Collectively, these results suggest that aloesin stimulates the proliferation of SK‐HEP‐1 cells by inducing the intracellular levels of cyclin E/CDK2 kinase complex and CDC25A, which, together, result in the up‐regulation of cyclin E‐dependent kinase activity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here